[1]姜 巍,刘亭亭,董亚丽,等.“糖尿病诊疗适宜技术培训”策略的成本效果分析[J].卫生经济研究,2022,39(5):21-26.
　JIANG Wei,LIU Ting-ting,DONG Ya-li,et al.Cost-Effectiveness Analysis of Training of Appropriate Technologies for Managing Diabetes[J].Journal Press of Health Economics Research,2022,39(5):21-26.
点击复制

“糖尿病诊疗适宜技术培训”策略的成本效果分析
分享到：

卫生经济研究[ISSN:1004-7778/CN:33-1056/F]

卷:
39
期数:
2022年5期
页码:
21-26
栏目:
卫生技术评估
出版日期:
2022-04-27

文章信息/Info

Title:
Cost-Effectiveness Analysis of Training of Appropriate Technologies for Managing Diabetes
作者:
姜 巍1; 刘亭亭1; 董亚丽1; 刘克军1; 2; 邱英鹏1; 2; 史黎炜1; 2; 曹艳丽3; 汤艳清3; 肖 月1; 2
1.国家卫生健康委卫生发展研究中心，北京100044
2.国家药物和卫生技术综合评估中心，北京100044
3.中国医科大学附属第一医院，辽宁 沈阳 110001
Author(s):
JIANG Wei;  LIU Ting-ting;  DONG Ya-li;  LIU Ke-jun;  QIU Ying-peng;  SHI Li-wei;  CAO Yan-li;  TANG Yan-qing;  XIAO Yue
National Health Development Research Center, Beijing 100044, China
关键词:
慢性病诊疗适宜技术; 糖尿病; 成本效果分析; Markov模型
Keywords:
appropriate technologies for managing diabetes;  diabetes;  cost-effectiveness analysis;  Markov model
分类号:
R19
文献标志码:
A
摘要:
目的：对“糖尿病诊疗适宜技术培训”策略进行成本效果分析。方法：根据糖尿病自然史构建Markov模型，以一年为1个周期，测算20个周期内不同健康状态的概率、QALY值和成本投入，计算培训策略的增量成本效果比，评价其经济性。结果：干预组累计成本为140 046.99元，累计效果为7.56个QALYs；未干预组的累计成本为161 446.31元，累计效果为6.98个QALYs；干预组增量成本效果比为-36 895.38元/QALY。结论：“糖尿病诊疗适宜技术培训”策略不但节省了全社会的糖尿病直接医疗费用，而且延长了糖尿病患者的健康寿命，具有显著的经济学优势。
Abstract:
Objective To evaluate cost-effectiveness of training of appropriate technologies for managing diabetes. Methods According to the natural history of diabetes, the Markov model was constructed, and one year was used as a cycle to measure the probability, QALY value and cost input of different health states in 20 cycles, and calculated the incremental cost-effectiveness ratio of the training strategy and evaluated its economy. Results The cumulative cost of the intervention group was 140 046.99 yuan, and the cumulative effect was 7.56 QALYs. The cumulative cost of the non-intervention group was 161 446.31 yuan, and the cumulative effect was 6.98 QALYs. The incremental cost-effectiveness ratio of the intervention group was -36 895.38 yuan/QALY. Conclusions The strategy of training of appropriate technologies for managing diabetes not only saves the direct medical costs of diabetes, but also prolongs the healthy life of diabetic patients, which has significant economic advantages.

参考文献/References:

[1] 冷瑶.我国中老年糖尿病患者疾病经济负担及风险研究[D].重庆：重庆医科大学，2020.
[2] 林喜铃.1990—2017年糖尿病的全球、地区和国家的疾病负担分析[D].杭州：浙江大学，2020.
[3] 国家心血管病中心.中国心血管健康与疾病报告2020[M].北京：科学出版社，2020.
[4] 陈嘉丰.2020年我国系统别慢性病治疗费用的预测[D].北京中医药大学，2013：28-30.
[5] 吴蕾.社区“5+1”糖尿病分阶段达标管理模式干预效果与成本分析[D].北京：中国疾病预防控制中心，2018.
[6] 徐永刚.基层社区医院对糖尿病患者实施规范化管理的效果与成本[J].临床合理用药杂志，2014，7（19）：138.
[7] 国家统计局.数据查询[EB/OL].https://data.stats.gov.cn/easyquery.htm?cn=C01.
[8] 陈兴宝，唐玲，陈慧云，等.2型糖尿病并发症对患者治疗费用的影响评估[J].中国糖尿病杂志，2003，11（4）：238-241.
[9] 国家统计局.中国统计年鉴2020.数据查询[EB/OL].https://data.stats.gov.cn/easyquery.htm?cn=C01.
[10] 吴杰龙.厦门市糖尿病“三师共管”模式卫生经济学评价[D].厦门：厦门大学，2018.
[11] Xie XQ,Hindrik Vondeling. Cost-Utility Analysis of Intensive Blood Glucose Control with Metforheartn versus Usual Care in Overweight Type 2 Diabetes Mellitus Patients in Beijing,P.R.China[J].Value in Health,2008,11.
[12] 谢琨.中国2型糖尿病患者生命质量评价及影响因素分析[D].天津：天津大学，2014.
[13] Zhang Y,Shi L,Wu J,Chen Y. EQ-5D-3L Decrements By Diabetes Complications and Comorbidities in China[J].Value in Health,2018, 21.
[14] 国家统计局.中国统计年鉴2020.数据查询[EB/OL].http://www.stats.gov.cn/tjsj/ndsj/2020/indexch.htm.
[15] 陈丽萍，陶立波.生活方式干预联合二甲双胍与单纯生活方式干预治疗糖尿病前期的长期成本-效果分析[J].中国药物经济学，2019，14（9）：18-23,38.

相似文献/References:

[1]李 田,马 利.中医院糖尿病患者住院总费用的通径分析[J].卫生经济研究,2017,(10):33.
[2]宋晨晓,徐爱军.高血压、糖尿病患者健康状况和卫生服务利用研究[J].卫生经济研究,2018,(04):60.
[3]周尚成,田 苗,陈霞平,等.糖尿病患者社会经济地位与失能权重相关性研究[J].卫生经济研究,2018,(10):21.
　ZHOU Shang-cheng,TIAN Miao,CHEN Xia-ping,et al.Correlation between Socioeconomic Status and Disability Weight of Diabetic Patients[J].Journal Press of Health Economics Research,2018,(5):21.
[4]冷 瑶,李燕喃,邓 晶.我国中老年糖尿病患者的疾病经济负担分析[J].卫生经济研究,2018,(10):47.
　LENG Yao,LI Yan-nan,DENG Jing.Analysis of the Economic Burden of Diseases in Middle-aged and Elderly Patients with Diabetes in China[J].Journal Press of Health Economics Research,2018,(5):47.
[5]杜晓莉,王秋霞,刘 斌,等.重庆市医联体内分级诊疗效果研究——以糖尿病诊疗为例[J].卫生经济研究,2019,(04):31.
　DU Xiao-li,WANG Qiu-xia,LIU Bin,et al.Study on the Effect of Grading Diagnosis and Treatment in Chongqing Medical Association——Taking Diabetes Diagnosis and Treatment as An Example[J].Journal Press of Health Economics Research,2019,(5):31.
[6]赵东辉,宋大平,汪早立,等.农村高血压、糖尿病患者签约服务试点及效果分析[J].卫生经济研究,2019,(05):34.
　ZHAO Dong-hui,SONG Da-ping,WANG Zao-li,et al.Pilot Family Doctor Contract Service and Effect Analysis of Rural Hypertension and Diabetes Patients[J].Journal Press of Health Economics Research,2019,(5):34.
[7]黎倩欣,周尚成,陈飘飘,等.深圳市糖尿病疾病经济负担研究[J].卫生经济研究,2021,38(3):63.
　LI Qian-xin,ZHOU Shang-cheng,CHEN Piao-piao,et al.Study on the Economic Burden of Diabetic Diseases in Shenzhen[J].Journal Press of Health Economics Research,2021,38(5):63.
[8]綦军帅,简伟研.中老年糖尿病患者直接医疗负担公平性研究[J].卫生经济研究,2022,39(8):59.
　QI Junshuai,JIAN Weiyan.Study on the Fairness of Direct Medical Burden of Middle-Aged Elderly with Diabetes[J].Journal Press of Health Economics Research,2022,39(5):59.
[9]陈蒙恩,杨敬宇,孔凡心,等.糖尿病患者住院费用影响因素分析 ——基于多重线性回归、决策树、通径分析3种模型[J].卫生经济研究,2023,40(4):84.
　CHEN Mengen,YANG Jingyu,KONG Fanxin,et al.Comparative Analysis of Influencing Factors on Hospitalization Cost of Diabetic Patients ——Based on Three Models of Multiple Linear Regression, Decision Tree and Path Analysis[J].Journal Press of Health Economics Research,2023,40(5):84.
[10]李 悦,邓世虎,张 进,等.医保主导的家庭医生签约服务试点效果分析 ——基于M市“两病”患者监测数据[J].卫生经济研究,2025,42(04):33.
　LI Yue,DENG Shihu,ZHANG Jin,et al.Analysis of the Pilot Effectiveness of Family Doctor Contracted Service Led by Medical Insurance ——Based on the Monitoring Data of Patients with "Two Diseases" in M City[J].Journal Press of Health Economics Research,2025,42(5):33.

更新日期/Last Update: 2022-04-27